Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label written parliamentary question
publisher
tabling member	label

Search

1249011

human indexable
published
registered interest
answer date	18/11/2020
date	04/11/2020
date tabled	04/11/2020
ddp created	04/11/2020 22:36:27
answering body	Department for Business, Energy and Industrial Strategy
question status	Tabled
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
ddp modified	06/11/2020 18:45:12 18/11/2020 16:50:10
hansard heading	flypop: Finance
house id	2
identifier	HL10002
legislature	25277
parliament number	58
question first answered	18/11/2020 16:18:26
question text	To ask Her Majesty's Government what environmental requirements they have imposed on FlyPop as a condition of the funding they awarded to that company; what are the requirements of that funding in relation to Civil Aviation Authority registration; and what due diligence processes were applied to that funding decision.
session	2019/21
session number	1
tabling member printed	Baroness Randerson
title	House of Lords Tabled Parliamentary Question 2019/21 HL10002
type	WrittenParliamentaryQuestion
uin	HL10002
version	2
written parliamentary question type	Ordinary
answer	answer
creator	4230 label Biography information for Baroness Randerson
publisher	25277
tabling member	4230 label Biography information for Baroness Randerson

1659267

human indexable
published
registered interest
answer date	21/09/2023
date	07/09/2023
date tabled	07/09/2023
ddp created	07/09/2023 19:51:54
answering body	Department for Business and Trade
question status	Tabled
answering dept id	214
answering dept short name	Business and Trade
answering dept sort name	Business and Trade
ddp modified	11/09/2023 21:45:42 21/09/2023 15:44:13
hansard heading	Property: Foreign Companies
house id	2
identifier	HL10002
legislature	25277
parliament number	58
question first answered	21/09/2023 15:43:27
question text	To ask His Majesty's Government what steps they are taking to identify the beneficial ownership of 100,000 properties held by foreign shell companies on behalf of others as disclosed by the report published on 4 September by the London School of Economics and Political Science, the University of Warwick and the Centre for Public Data.
session	2022/23
session number	3
tabling member printed	The Lord Bishop of Southwark
title	House of Lords Tabled Parliamentary Question 2022/23 HL10002
type	WrittenParliamentaryQuestion
uin	HL10002
version	2
written parliamentary question type	Ordinary
answer	answer
creator	4345 label Biography information for The Lord Bishop of Southwark
publisher	25277
tabling member	4345 label Biography information for The Lord Bishop of Southwark

967515

human indexable
published
registered interest
answer date	18/09/2018
date	04/09/2018
date tabled	04/09/2018
ddp created	04/09/2018 20:33:50
answering body	Department of Health and Social Care
question status	Tabled
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
ddp modified	04/09/2018 20:38:44 17/09/2018 14:24:01
hansard heading	NHS: Drugs
house id	2
identifier	HL10002
legislature	25277
parliament number	57
question first answered	17/09/2018 13:52:59
question text	To ask Her Majesty's Government, further to the answer by Lord O'Shaughnessy on 7 June (HL Deb, col 1405), what assessment they have made of the credibility of the National Institute for Health and Care Excellence (NICE) process to approve drugs for use by NHS England; and what discussions they have held with NHS England on the subject of the application of NICE standards for Ibrutinib.
session	2017/19
session number	1
tabling member printed	Baroness Prosser
title	House of Lords Tabled Parliamentary Question 2017/19 HL10002
type	WrittenParliamentaryQuestion
uin	HL10002
version	1
written parliamentary question type	Ordinary
answer	answer
creator	3684 label Biography information for Baroness Prosser written parliamentary question 967515
publisher	25277
tabling member	3684